Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 160 results found. Search for [ Pfizer vaccine candidate ]

Results 60 to 80 of 160
PTI
November 10, 2020
They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines


Anwesha Madhukalya
November 10, 2020
Pfizer and BioNTech coronavirus vaccine: Logistical challenges such as ultra-low temperature storage could hamper the distribution plans not only in developing nations like India but also in advanced countries like the US


Rajeev Dubey
New Delhi, November 10, 2020
In a major breakthrough in COVID-19 vaccine work, American pharmaceutical giant Pfizer and German firm BioNTech claimed that their vaccine candidate has been found to be 90% effective. The vaccine firms are the first drugmakers to show successful data from a large-scale clinical trial of coronavirus vaccine. The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world. How Pfizer vaccine will act as a game changer for the US market, Rajeev Dubey, Editor, Business Today explains.Also Read: Sensex crosses 43,000 for first time, Nifty nears 12,600 on COVID-19 vaccine hopes


Shailendra Shukla
New Delhi, November 10, 2020
Wipro employees to get single digit pay hike effective December 1 IT major Wipro will offer a single digit salary hike as well as promotions to its high quality performers effective December 1. Pay hike and promotions will be rewarded to employees in bands up to B3 account, who constitute about 80 per cent of the company's total workforce. The company is yet to take a decision on offering salary increments to senior employees above B3 band. Tanishq withdraws another Diwali ad after Twitte...


BusinessToday.In
November 10, 2020
India Stock Market Highlights Today: ICICI Bank followed by ONGC, HDFC, L&T, SBI, HDFC Bank, IndusInd Bank and Bajaj Finance were among the top gainers on Sensex today. On the other hand, Tech Mahindra, Infosys, HCL Tech, TCS, Nestle India and Maruti were in the red


BusinessToday.In
November 10, 2020
Sputnik V vaccine, developed by the Gamaleya National Research Institute of Epidemiology, was registered by the Russian Health Ministry


BusinessToday.In
November 10, 2020
Coronavirus vaccine: BioNTech Chief Executive Ugur Sahin, 55, son of Turkish immigrants who worked at the Ford factory in Cologne is now one of the 100 richest Germans, along with wife and board member Oezlem Tuereci, 53


PTI
November 10, 2020
Pfizer said that the vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis


BusinessToday.In
November 9, 2020
In premarket trade on Monday, BioNTech SE shares rallied over 24 per cent, while Us-based Pfizer Inc. stock jumped over 14 per cent after their COVID-19 vaccine candidate achieved positive results in first interim analysis from Phase 3 study


Chitranjan Kumar
November 9, 2020
Coronavirus vaccine update: Based on current projections, Pfizer Inc and BioNTech expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


PTI
October 31, 2020
The UK is committed to ensuring that everyone at risk of SARS-CoV-2 infection, anywhere in the world, has access to a safe and effective vaccine, said Bingham


Reuters
October 29, 2020
While the company did not give a clear timeline on the release of data from these trials on Thursday, it has said that early data is expected in the coming weeks


BusinessToday.In
October 28, 2020
Kate Bingham, the chair of the UK government's vaccine taskforce said that a COVID-19 vaccine could be rolled out in Britain for some people before Christmas but an early 2021 launch is more likely


BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


PTI
October 20, 2020
Israel had claimed in August that it already has the vaccine against the coronavirus \"in hand\" but it has to go through regulatory processes that would begin with human trials following the autumn holidays


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


BusinessToday.In
October 13, 2020
Johnson & Johnson sent out a document in which it stated the \"pausing rule\" has been met and the online system used to enrol patients in the study has been closed


PAGES 4 OF 8  12345